Skip to main content
logo
Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
3.994
-0.016 (-0.41%)
Oct 2, 2026, 11:20 AM EDT - Market open

Edesa Biotech Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-14.63-7.91-7.01-9.22-18.37-23.68
Net Income
-14.1-7.19-6.17-8.37-17.55-13.34
Earnings Per Share
-1.73-1.27-1.93-2.93-8.37-7.73
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
10.3310.791.045.367.097.84
Total Debt
--0.020.090.020.1
Net Cash (Debt)
10.3310.791.025.277.077.74
Net Cash Growth
-16.41%960.70%-80.68%-25.52%-8.63%9.79%
Net Cash Per Share
1.271.900.321.843.374.49

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-8.91-7.32-4.89-6.64-12.28-13.66
Capital Expenditures
-----0.01-0.01
Free Cash Flow
-8.91-7.32-4.89-6.64-12.28-13.67
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Forward PE
-0.880.880.8856.67-
PS Ratio
------